Stay Informed on Key Developments

Investor News and Updates

Bill_Ipad

Stay informed about key developments at our company as they happen. Discover our Ad-Hoc Releases and subscribe to our newsletter to receive the latest news and topics of interest.

71 - 80of 392 News
71 - 80of 392 News
March 01, 2023
Not intended for U.S. and UK Media
Bayer submits aflibercept 8 mg for marketing authorization in Japan
READ MORE
February 28, 2023
Fiscal 2022
Bayer: Significant growth in sales and earnings
READ MORE
February 27, 2023
Not intended for U.S. and UK Media
Nubeqa™ approved for additional indication in Japan
READ MORE
February 10, 2023
Not intended for U.S. and UK Media
Kerendia™ (finerenone) granted expanded indication in the EU for broad range of patients with chronic kidney disease and type 2 diabetes
READ MORE
February 08, 2023
Bill Anderson to become CEO of Bayer AG
READ MORE
February 06, 2023
Not intended for U.S. and UK Media
Bayer submits aflibercept 8 mg for regulatory approval in two major retinal eye diseases in the EU
READ MORE
February 02, 2023
Bayer and Kimitec join forces to bring the next generation of Biologicals to millions of growers worldwide
READ MORE
January 31, 2023
Bayer to distribute pheromone-based biological crop protection solutions from M2i Group
READ MORE
January 27, 2023
Not intended for U.S. and UK Media
CHMP recommends Bayer’s darolutamide for the treatment of metastatic hormone-sensitive prostate cancer
READ MORE
January 19, 2023
Bayer launches new collaboration with Oerth Bio to further advance innovations in crop protection
READ MORE
71 - 80of 392 News
71 - 80of 392 News
Inform Yourself on Special Topics
Control Weeds Not Farming

Control Weeds, Not Farming

LEARN MORE
Farmers discussing their weed management

Everything You Need to Know About Glyphosate

LEARN MORE
some-bayer-group-headquarters

Managing Glyphosate Litigation

learn more
woman harvesting carrots

Managing and Mitigating PCB Litigation Risk

learn more